JPRN-UMIN000000643CompletedPhase 4
A open-label study of Entecavir in the patients with acute hepatitis B for preventing chronicity and aggravation - GLSG,2006,Acute hepatitis B
Gunma Liver Study Group0 sites20 target enrollmentStarted: October 1, 2013Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Sponsor
- Enrollment
- 20
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Fulminant hepatitis During pregnancy and the possibility of pregnancy Participating in the other clinical trials
Investigators
Similar Trials
Completed
Phase 4
A open-label study of entecavir for chronic hepatitis B to determine the optimum duration of administratiochronic hepatitis BJPRN-UMIN000000644Gunma Liver Study Group70
Active, not recruiting
Not Applicable
A Study of the Safety and Efficacy of Entecavir plus Tenofovir in Adults with Chronic Hepatitis B Virus Infection with Previous Nucleoside/Nucleotide Treatment Failure. - NDEUCTR2009-015705-40-ITBristol-Myers Squibb International Corporation125
Recruiting
Not Applicable
Efficacy of preceding administration of Entecavir with PEG-IFN-alfa2a for patients with chronic hepatitis B, positive with HBe antigen in young aged populationsChronic hepatitis BJPRN-UMIN000020124Division of Gastroenterology and Hepatology, Department of Internal Medicine, St. Marianna University School of Medicine,26
Recruiting
Not Applicable
Randomized trial of new oral anti hepatitis B drug (entecavir) plus interferon versus another oral anti hepatitis B drug (lamivudine) plus interferon in chronic hepatitis B in children.CTRI/2016/04/006820jjal Poddar
Completed
Phase 4
A multicenter open-label trial of entecavir treatment for chronic hepatitis B and cirrhosis: Effectiveness and safetyChronic hepatitis B and cirrhosisJPRN-UMIN000000594Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences65